Competing interests of UKCTCS staff

John Britton chairs the Royal College of Physicians Tobacco Advisory Group and is a member of the board of trustees of Action on Smoking and Health

Peter Hajek undertakes consultancy for and has received research funds from a number of companies developing and manufacturing smoking cessation products.

Paul Aveyard has accepted hospitality from the pharmaceutical industry.  He has done consultancy and research work in smoking cessation for Pfizer, McNeil, and Xenova Biotechnology that has led to payments to him and his research account.

Linda Bauld is vice-chair of the Cancer Research UK Tobacco Advisory Group and serves as Scientific Adviser to the Department of Health on tobacco control.

Tim Coleman has, within the last 5 years, done occasional consultancy work for companies that manufacture NRT products (Johnson and Johnson, Pierre Fabre Laboratories).  He has also advised a Public Relations company on the strength of the evidence for using Nicobloc as an aid for smoking cessation.

Robert West undertakes research and consultancy for companies that develop and manufacture smoking cessation medications. He has a share of a patent for a novel nicotine delivery device. He is a trustee of QUIT. His research is funded mostly by Cancer Research UK.